We extend our most sincere thanks to Alexandria Ventures for sponsoring our 2026 Health Policy Conference. Their support will allow us to continue gathering annually and host these crucial health policy conversations. Learn more about Alexandria here: www.are.com

Our annual conference is just a few days away! Join us this Wednesday, May 13, for an afternoon packed with timely health policy discussions as we celebrate 10 years of Duke-Margolis. Register today: duke.is/HPC2026

We’re excited to discuss many timely health policy topics at the 2026 Health Policy Conference! This event is only made possible through our sponsors, so we would like to thank the Peterson Center on Healthcare for their support. The Center was established by the Peter G.

The Duke-Margolis ReVAMP Drug Supply Consortium has released a new Framework to Address Chronic Drug Shortages, which outlines six priority areas where the federal government can respond to chronic drug shortages that create higher mortality rates, medication errors, delays in

We would like to thank Johnson & Johnson for their generous support of our upcoming conference! J&J has been tackling the world’s toughest health challenges for 140 years, aiming to keep people well at every age and every stage of life: www.jnj.com/our-company

A draft agenda is now available for our upcoming meeting! Join us on May 19 as we explore solutions to chronic drug shortages, national health security risks associated with foreign dependence, and challenges related to quality assurance: duke.is/v/4g5n

Our 2026 Health Policy Conference is just around the corner! We would like to thank Alexandria Ventures for sponsoring this event that creates an important space for health policy discussion.

WEDNESDAY: Join Duke-Margolis and the U.S. Food and Drug Administration (FDA) for a public webinar to provide updates on RCT-DUPLICATE, one of the FDA’s demonstration projects addressing key methodological challenges in studies using real-world data. Register today: duke.is/4/5a35

Congratulations to Research Director Rachele Hendricks-Sturrup for being inducted into the inaugural class of Fellows of the Association for Clinical and Translational Science (ACTS)! Read more here: duke.is/2/qksh

You won't want to miss this upcoming event! On May 19, we are hosting a hybrid meeting to discuss strategies to strengthen domestic drug supply chain reliability. Join us as we explore solutions to chronic drug shortages: duke.is/v/4g5n

This Thursday: Join Duke-Margolis and the U.S. Food and Drug Administration for a conversation on "Increasing Access to Nonprescription Drugs"! Register today: duke.is/p/4g3b

Join Duke-Margolis and the FDA on April 29 for a free webinar on RCT-DUPLICATE, a demonstration project on using real-world data to generate valid evidence. Learn how studies can emulate trials and support regulatory decisions. Register today: duke.is/4/5a35

How can we transform health and improve health outcomes in the rural United States? Speakers will explore this issue during a session at the Duke-Margolis 2026 Health Policy Conference on May 13. Join us for this conversation and a wide range of other timely health policy topics! duke.is/HPC2026

Join us for a special Duke-Margolis Seminar featuring Anup Malani, Chief Economist at CMS! Enrollment in ACA individual market plans with zero claims raises important questions about enrollee health status, coverage transitions to Medicaid, and the potential for improper enrollment: duke.is/m/9e8n

Don't miss our 2026 Health Policy Conference, where speakers will explore some of the most pressing health policy challenges facing the United States. Join us as we reflect on progress and look ahead to new opportunities to improve health and health care for all: duke.is/HPC2026

Our next event is just a few days away! Don't miss your chance to register for "Scaling Innovative Clinical Trial Approaches: Challenges, Progress, and Opportunities," where speakers will explore strategies to encourage broader adoption of innovative clinical trial approaches: duke.is/m/qy4t

Check out the new draft agenda for our upcoming event, "Increasing Access to Nonprescription Drugs!" Speakers will explore opportunities to improve individual and public health outcomes through nonprescription treatments. Read more and register here: duke.is/p/4g3b

As clinical tools are embedded in clinical care, new opportunities to improve patient care increase but so do new patient safety risks.

Registration closes soon! Join us on Monday for the third workshop in the RISE series, co-convened with the FDA Rare Disease Innovation Hub, where our expert speakers will explore the potential of data sharing to advance rare disease clinical trials and medical product development: duke.is/2/t6dr

A new hybrid meeting has been announced! Join us on April 23 for this event, hosted under a cooperative agreement with the FDA, that will explore opportunities to increase access to nonprescription drugs. Register today: duke.is/p/4g3b

Don't miss our upcoming hybrid workshop co-convened with the FDA's C3TI! On 4/14, we are gathering expert speakers to discuss C3TI activities as well as strategies to advance broader adoption of innovative approaches in clinical trial design and conduct: duke.is/m/qy4t

Don't miss the 2026 Duke MBA Health Care Conference on March 25! Dev Sangvai, Secretary of NC DHHS, is the keynote speaker at the event. And hear from our Senior Research Director, Marianne Hamilton Lopez, as well as Core Faculty member David Ridley. Register here: dukembahealthcareconference....

Speakers have been announced! Join us in just a few weeks for a hybrid workshop exploring how data sharing can advance rare disease therapy development. In particular, speakers will share case examples of data sharing in practice, featuring different types of data. Register here: duke.is/2/t6dr

Happening March 24: @dukeaihealth.bsky.social and @dukemargolis.bsky.social are hosting a webinar titled, 'From Deployment to Oversight: Strengthening AI Risk Management and Patient Safety in Health Care,' that will explore strategies to protect patients in the age of AI! To register: duke.is/5/cg7u

In just a few weeks, we are co-hosting an event with the Duke Health AI Evaluation & Governance Program! As clinical AI tools are increasingly embedded in care delivery, proactive risk management is needed. Join us on 3/24 and explore strategies to protect patients in the age of AI: duke.is/5/cg7u

Join us this Friday for our next public webinar! We look forward to discussing the CIC's new Health Value Evidence Quality Framework, which outlines stages of evidence quality analysis across the investment life cycle and highlights real-world case examples. Register here: duke.is/w/65xf

The new Health Value Evidence Quality (HV-EQ) Framework from our Capital Impact Council (CIC) outlines guidance to help assure private investments in health care deliver health value alongside financial returns: duke.is/HVEQ

In his recent testimony to the U.S.–China Economic and Security Review Commission, Visiting Fellow Chan Harjivan underscored that America’s drug supply chain is a matter of national security, not just health policy, as demonstrated by the COVID pandemic. Read the full testimony here: duke.is/z/v5hu

The Duke-Margolis Capital Impact Council has released a new framework to help private investors generate stronger evidence that their investments improve health and health care. Learn more about the framework during this webinar on 3/6: duke.is/w/zf4y

Duke-Margolis has released a new white paper! The authors discuss best practices for curation of real-world data sourced from electronic health records, aiming to preserve clinical meaning and analytical reliability. Read more here: duke.is/b/n2dv

Our next public event starts in an hour! One of the collaborative efforts that will be highlighted in today's webinar is the West Health & Duke-Margolis Accelerator's Accountable Care Learning Hub, which provides many useful resources for accountable care transformation:

Our next event is just a few days away! There's still time to register for the rapid learning webinar we are hosting with support from West Health. Speakers will explore how collaborative action can advance rapid learning and, in turn, address accountable care policy challenges: duke.is/6/ef23

Don't miss your chance to register! Join us next week for a webinar where attendees will learn more about how rapid learning collaboratives can address urgent accountable care policy challenges. We look forward to hearing insights from a group of wonderful speakers! Register here: duke.is/6/ef23

Mark your calendars for the 2026 Health Policy Conference: Driving Health Policy Transformation in the Next Decade! Join us in DC as leading health policy experts explore the past, present, and future of health policy in an ever-changing landscape. Learn more and register here: duke.is/HPC2026Web

Check out the new draft agenda! On February 19, we are hosting a webinar with West Health to discuss how rapid learning can accelerate accountable care adoption, and how collaborative action can promote faster learning. Learn more and register here: duke.is/6/ef23

April 14: Join us for a hybrid public workshop, co-convened with the FDA's C3TI, where speakers will explore progress in clinical trial innovation to improve the efficiency of drug development. More information is coming soon! Register here to secure your spot: duke.is/m/qy4t

Join us on March 30 for the third RISE workshop, "RISE Together: Data Sharing Across the Rare Disease Ecosystem." This event will explore data sharing as it pertains to informing development and regulatory review for rare disease therapies. Space is filling fast! Register today: duke.is/2/t6dr

There’s still time to register! The 10th Anniversary of the HCPLAN: Celebrating a Decade of Advancing Value-Based Care virtual event takes place on 2/2 from 2-4pm ET. Hear from Mark McClellan as speakers reflect on a decade of progress and look toward the future. Register today: bit.ly/4qzHuP0

Looking for resources to support accountable care transformation? The West Health & Duke-Margolis Accelerator website hosts a body of health policy research driven by our partnership with West Health as we have sought to advance better care across the U.S. health system: www.acceleratecare.org/

Bass Connections project teams for 2026-27 have been announced! Several research projects fall under the Health Policy and Innovation theme, covering issues such as accessible housing, child and family health, advancing health education, and more. Applications are open until 2/9! duke.is/z/vxcj

Our first event of 2026 has been announced! Join us for a webinar on 2/19 to learn more about how rapid learning can be used to accelerate accountable care. In particular, we will discuss CMMI's RCIP as well as Duke-Margolis and West Health's Accountable Care Learning Hub. Register: duke.is/6/ef23

Welcome back, Duke students! Don't forget that our Undergraduate Scholar applications are open until 1/12. Our Margolis Scholars program is a great supplement to your degree program that can provide you with the competencies needed for a career in health policy: healthpolicy.duke.edu/scholars

Congratulations to our real-world evidence team! Last week, Duke-Margolis researchers presented posters at the Duke Precision Genomics Collaboratory Scientific Retreat. One poster won a best poster award and research grant! Read the paper from the winning poster here: duke.is/5/ygcs

Our last event of 2025 is just a few days away—don't miss your chance to register! Join us next Tuesday, December 16, in our DC office as speakers explore ways to improve access to epinephrine and reduce anaphylaxis-related morbidity and mortality. Learn more and register here: duke.is/y/x7xs

How can Medicaid agencies continue to make progress on community health and well-being in today’s policy environment? A new issue brief drawing on community-based research published with @dukemargolis.bsky.social identifies 6 strategies.

Core Faculty member Matt Maciejewski has co-authored a JAMA Viewpoint article that discussed how real-world evidence studies can be best used to inform Medicare drug price negotiations. Read the authors' guidance here: duke.is/n/7r2w

Institute Director Mark McClellan and 11 other former U.S. Food and Drug Administration Commissioners express their concern for recently announced changes in the FDA’s regulatory model for vaccines in a new article published by the New England Journal of Medicine. Read more here: duke.is/w/7bqt

Institute Director Mark McClellan and Research Director Christina Silcox have released a statement on the new CMS ACCESS Model, which aims to improve the health of people with chronic disease and covered by Traditional Medicare, through technology-supported care. Read our statement: duke.is/j/tqrq

A summary of the recent Duke Climate Collaboration Symposium focused has been published! Co-hosted by Duke-Margolis & the School of Medicine, the event convened leaders across disciplines to explore how the health care landscapes can adapt and lead in the face of a changing climate: duke.is/w/yu9h

Duke-Margolis researchers Montgomery Smith and Frank McStay co-authored a paper in the Journal of the American Medical Directors Association that studied stakeholder feedback on the potential development of a home-based primary care practice recognition program: duke.is/n/tvd2